Clinical Trial Update: Zoledronate In the Prevention of Paget's Disease: Long Term Extension

View source ↗

Summary

A long-term extension trial evaluating zoledronate for the prevention of Paget's disease is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of Bone

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: University of Edinburgh | Conditions: Paget Disease | Status: ENROLLING_BY_INVITATION